STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive: STAT3 dephosphorylation can sensitize doxorubicin-resistant Dalton lymphoma to dendritic cell (DC)-derived TNF-α through the downregulation of Bcl-2 upon cucurbitacin I (STAT3 inhibitor) treatment in DC (chronic myeloid leukemia) patients [105].